Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G J Ossenkoppele

Showing results (91-100 of 152) with videos related to

Pageof 16
Sort By:
Leukemia|October 7, 2015
A simple one-tube assay for immunophenotypical quantification of leukemic stem cells in acute myeloid leukemiaW Zeijlemaker, A Kelder, Y J M Oussoren-Brockhoff, et al.
Leukemia|November 22, 1997
A functional study on the migration of human monocytes to human leukemic cell lines and the role of monocyte chemoattractant protein-1M C Legdeur, R H Beelen, G J Schuurhuis, et al.
Leukemia|June 24, 2000
P-glycoprotein in primary acute myeloid leukemia and treatment outcome of idarubicin/cytosine arabinoside-based induction therapyH J Broxterman, P Sonneveld, W J van Putten, et al.
Leukemia|October 6, 2001
Functional characterization of minimal residual disease for P-glycoprotein and multidrug resistance protein activity in acute myeloid leukemiaM A van der Pol, J M Pater, N Feller, et al.
Leukemia|January 17, 2003
High percentage of CD34-positive cells in autologous AML peripheral blood stem cell products reflects inadequate in vivo purging and low chemotherapeutic toxicity in a subgroup of patients with poor clinical outcomeN Feller, G J Schuurhuis, M A van der Pol, et al.
Histopathology|March 4, 2008
Expression of TNF-receptor associated factor 2 correlates with poor progression-free survival time in ABC-like primary nodal diffuse large B-cell lymphomasJ C van Galen, J J F Muris, C P E Giroth, et al.
Leukemia|September 17, 2015
Peripheral blood minimal residual disease may replace bone marrow minimal residual disease as an immunophenotypic biomarker for impending relapse in acute myeloid leukemiaW Zeijlemaker, A Kelder, Y J M Oussoren-Brockhoff, et al.
Leukemia|October 27, 1997
Hypersensitivity of bcr-abl-positive progenitors to hyperthermia in patients with chronic myeloid leukemiaS F Thijsen, J W van Oostveen, G J Schuurhuis, et al.
Experimental Hematology|April 1, 1993
Spectrophotometric determination of clonogenic capacity of leukemic cells in a semisolid microtiter culture systemC M Schweitzer, A A van de Loosdrecht, A R Jonkhoff, et al.
Leukemia|June 18, 2004
MRD parameters using immunophenotypic detection methods are highly reliable in predicting survival in acute myeloid leukaemiaN Feller, M A van der Pol, A van Stijn, et al.
Pageof 16

Showing results (91-100 of 152) with videos related to

Sort By:
Pageof 16
Leukemia|October 7, 2015
A simple one-tube assay for immunophenotypical quantification of leukemic stem cells in acute myeloid leukemiaW Zeijlemaker, A Kelder, Y J M Oussoren-Brockhoff, et al.
Leukemia|November 22, 1997
A functional study on the migration of human monocytes to human leukemic cell lines and the role of monocyte chemoattractant protein-1M C Legdeur, R H Beelen, G J Schuurhuis, et al.
Leukemia|June 24, 2000
P-glycoprotein in primary acute myeloid leukemia and treatment outcome of idarubicin/cytosine arabinoside-based induction therapyH J Broxterman, P Sonneveld, W J van Putten, et al.
Leukemia|October 6, 2001
Functional characterization of minimal residual disease for P-glycoprotein and multidrug resistance protein activity in acute myeloid leukemiaM A van der Pol, J M Pater, N Feller, et al.
Leukemia|January 17, 2003
High percentage of CD34-positive cells in autologous AML peripheral blood stem cell products reflects inadequate in vivo purging and low chemotherapeutic toxicity in a subgroup of patients with poor clinical outcomeN Feller, G J Schuurhuis, M A van der Pol, et al.
Histopathology|March 4, 2008
Expression of TNF-receptor associated factor 2 correlates with poor progression-free survival time in ABC-like primary nodal diffuse large B-cell lymphomasJ C van Galen, J J F Muris, C P E Giroth, et al.
Leukemia|September 17, 2015
Peripheral blood minimal residual disease may replace bone marrow minimal residual disease as an immunophenotypic biomarker for impending relapse in acute myeloid leukemiaW Zeijlemaker, A Kelder, Y J M Oussoren-Brockhoff, et al.
Leukemia|October 27, 1997
Hypersensitivity of bcr-abl-positive progenitors to hyperthermia in patients with chronic myeloid leukemiaS F Thijsen, J W van Oostveen, G J Schuurhuis, et al.
Experimental Hematology|April 1, 1993
Spectrophotometric determination of clonogenic capacity of leukemic cells in a semisolid microtiter culture systemC M Schweitzer, A A van de Loosdrecht, A R Jonkhoff, et al.
Leukemia|June 18, 2004
MRD parameters using immunophenotypic detection methods are highly reliable in predicting survival in acute myeloid leukaemiaN Feller, M A van der Pol, A van Stijn, et al.
Pageof 16